(RPTH), Folsom and colleagues report on the association between a migraine history and the risk of venous thromboembolism (VTE) in older adults.
In this issue of Research and Practice in Thrombosis and Haemostasis
(RPTH), Folsom and colleagues report on the association between a migraine history and the risk of venous thromboembolism (VTE) in older adults.
1 For this purpose, the authors carried out an analysis on the well-known cohort study "The Atherosclerosis Risk in Communities (ARIC) Cohort," in which patients were interviewed from 1993 through 1995 regarding migraine, and followed for subsequent VTE through 2013. The analytic population comprised nearly 12 000 individuals, and the authors concluded that a migraine history was not associated with an increased risk of VTE (adjusted hazard ratio, 1.06; 95% confidence interval [CI], 0.82-1.36). While no association was observed between migraine without aura and VTE (adjusted hazard ratio, 0.97; 95% CI, 0.71-1.32), a weak association between migraine with aura and VTE could not be entirely ruled out (adjusted hazard ratio, 1.25; 95% CI, 0.85-1.85).
So how does this study add to the literature? It has been established previously that migraine is linked to an increased risk of ischemic stroke, ischemic heart disease, and atrial fibrillation, particularly among women and among migraine patients with aura. [2] [3] [4] [5] Although the explanations for these associations are not fully understood, possible mechanisms involve endothelial dysfunction, hypercoagulability, platelet aggregation, vasospasm, presence of cardiovascular risk factors, paradoxical embolism, spreading depolarization, shared genetic risk, use of nonsteroidal anti-inflammatory drugs, and immobilization. [6] [7] [8] Some of these mechanisms may also contribute to the risk of other cardiovascular events. It should be noted that the magnitude of the increased cardiovascular risk associated with migraine observed in prior studies was fairly small at the absolute level, which is expected given the relatively young age of migraine patients, but it may translate into an increase in risk at the population level because migraine is a prevalent disease affecting around 1 billion people worldwide. of subjects with active and inactive migraine could not be distinguished. Clinically, migraine is characterized by recurrent headache episodes caused by increased excitability of the central nervous system with a peak in prevalence and incidence before the age of 50 years. Migraine is often ameliorated in older people, and thus it can be speculated that the analysis by Folsom et al included a large proportion of individuals with a history of migraine but without active migraine. If active migraine is in fact the exposure of interest, using the history of migraine as a proxy would lead to misclassification of the exposure and the measured effect would be diluted. In support of this notion, prior studies also suggested that the risk of VTE was particularly elevated in the short term following a migraine episode.
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Next to these insights on the association between migraine and venous thrombosis, there are 2 more general lessons to be learned.
First, the paper nicely shows the added value of nonbinary think- 
